76 related articles for article (PubMed ID: 9309783)
1. c-erbB-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Pathobiology; 1997; 65(3):163-8. PubMed ID: 9309783
[TBL] [Abstract][Full Text] [Related]
2. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
Ray A; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of co-overexpression of bcl-2 and c-erbB-2/neu in uterine cervix carcinomas and premalignant lesions.
Protrka Z; Arsenijević S; Arsenijević P; Mitrović S; Stanković V; Milosavljević M; Nedović J; Kastratović T; Durić J
Med Glas (Zenica); 2012 Aug; 9(2):248-55. PubMed ID: 22926359
[TBL] [Abstract][Full Text] [Related]
4. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract][Full Text] [Related]
5. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium.
Maruo T; Yamasaki M; Ladines-Llave CA; Mochizuki M
Cancer; 1992 Mar; 69(5):1182-7. PubMed ID: 1739918
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical studies on epidermal growth factor receptor (EGF-R) in gynecological malignant tumor].
Furugen Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):410-6. PubMed ID: 2066613
[TBL] [Abstract][Full Text] [Related]
9. Correlation between EGFR and c-erbB-2 oncoprotein status and response to neoadjuvant chemotherapy in cervical carcinoma.
Kim JW; Kim YT; Kim DK
Yonsei Med J; 1999 Jun; 40(3):207-14. PubMed ID: 10412330
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Tumour Biol; 2001; 22(3):176-83. PubMed ID: 11275796
[TBL] [Abstract][Full Text] [Related]
11. Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement.
Hayashi Y; Hachisuga T; Iwasaka T; Fukuda K; Okuma Y; Yokoyama M; Sugimori H
Gynecol Oncol; 1991 Feb; 40(2):147-51. PubMed ID: 1707025
[TBL] [Abstract][Full Text] [Related]
12. CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
Wobus M; Kuns R; Wolf C; Horn LC; Köhler U; Sheyn I; Werness BA; Sherman LS
Gynecol Oncol; 2001 Nov; 83(2):227-34. PubMed ID: 11606076
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
[TBL] [Abstract][Full Text] [Related]
14. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy.
Nakano T; Oka K; Taniguchi N
Cancer Res; 1996 Jun; 56(12):2771-5. PubMed ID: 8665512
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast.
Sharma BK; Ray A; Kaur S; Gupta S
Indian J Exp Biol; 1999 Mar; 37(3):223-7. PubMed ID: 10641149
[TBL] [Abstract][Full Text] [Related]
16. LA-1 oncogene. A possible new prognostic index for evaluating cervical squamous intraepithelial lesions.
Sainz de la Cuesta R; Reed TP; Brothman JC; Dubin NH
J Reprod Med; 1993 Mar; 38(3):173-8. PubMed ID: 8487232
[TBL] [Abstract][Full Text] [Related]
17. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of growth factor receptor-bound protein 10 in cervical squamous cell carcinoma.
Okino K; Konishi H; Doi D; Yoneyama K; Ota Y; Jin E; Kawanami O; Takeshita T
Oncol Rep; 2005 Jun; 13(6):1069-74. PubMed ID: 15870923
[TBL] [Abstract][Full Text] [Related]
19. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
20. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
